Predictive Factors Related to Salvage External Beam Re-irradiation for RecurrentHead and Neck Squamous Cell Carcinoma after Primary Radical Therapy

Background: Recurrent orsecond-primary tumor inhead and neck cancer (re-HNC) is achallenge. Curative approaches include definitive new course of RT (re -RT) combined to surgery and/or chemotherapy. Methods: We evaluated the data from 36 patients presenting re HNC who were treated between 2007 and 2011. Results:Twenty two (61.1%) patients had surgery and re -RT using IMRT. The median first radiation dose and interval between re-RT and the initial RT course were 60.0 Gy and 28 months. The median follow-up was 24 months. The 2 -and 5year actuarial OS, PFS and LC rates were 58.6%, 83.8%, 75.0%, 24.4%, 25.9% and 13.5%, respectively. On univariate analysis disease free interval > 24 months and free surgical margins, p=0.005 and p=0.012, where related to LC. Free surgical margin and re-RT with concurrent CHT were related to PFS, p=0.029 and p=0.001, respectively. IMRT when compared to other techniques showed LC and PFS advantages, p= 0.047 and p=0.050, respectively.Multimodality treatment (p=0.027) and free surgical margin (p=0.016) were related to improved OS. Cox regression multivariate analysis confirmed that patients who underwent re-RT with techniques other than IMRT, HR=8.68 (p= 0.003, 95% CI: 0.029 �0.491) and recurrence free interval < 24 months, HR=6.71 (p= 0.010, 95% CI: 0.039 �0.637) had an inferior PFS. Gross tumor after or absence of surgery were related to worse LC rates, HR=4.18 (p= 0.041, 95% CI: 0.040 � 0.934).Severe late complicat ions (Grade"e 3) occurred in 14 (38.8%) patients. Conclusion:Re-RT should be offered for patients who are not suitable for surgery or for those with marginal resections, with a clear understanding that severe toxicity is associated and

[1]  R. Tishler,et al.  Efficacy and toxicity of reirradiation using intensity‐modulated radiotherapy for recurrent or second primary head and neck cancer , 2010, Cancer.

[2]  A. Eisbruch,et al.  The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. , 2009, International journal of radiation oncology, biology, physics.

[3]  Adam S Garden,et al.  IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. , 2009, International journal of radiation oncology, biology, physics.

[4]  D. Goldstein,et al.  Outcomes following reirradiation of patients with head and neck cancer , 2008, Head & neck.

[5]  S. Spencer,et al.  Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck , 2008, Head & neck.

[6]  A. Markoe,et al.  Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[7]  K. Ang,et al.  Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Mechalakos,et al.  Salvage re-irradiation for recurrent head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[9]  E. Vokes,et al.  Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[10]  L. Kowalski,et al.  Interstitial high‐dose‐rate brachytherapy combined with cervical dissection on head and neck cancer , 2005, Head & neck.

[11]  E. Horwitz,et al.  Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split‐course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies , 2005, Head & neck.

[12]  C. Belka,et al.  Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. , 2005, International journal of radiation oncology, biology, physics.

[13]  C. R. Leemans,et al.  A review on re-irradiation for recurrent and second primary head and neck cancer. , 2005, Oral oncology.

[14]  G. Weinstein,et al.  Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[15]  A. Yuen,et al.  Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery , 2003, Head & neck.

[16]  D. Haraf,et al.  Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. , 2003, Cancer treatment reviews.

[17]  S. Spencer,et al.  RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. , 2001, International journal of radiation oncology, biology, physics.

[18]  N. Willich,et al.  Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. , 2000, Radiology.

[19]  W. Goodwin Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means? , 2000, The Laryngoscope.

[20]  S. Stringer,et al.  Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. , 1995, International journal of radiation oncology, biology, physics.

[21]  K. Stevens,et al.  High-dose reirradiation of head and neck cancer with curative intent , 1994 .

[22]  L. Hutchins,et al.  Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Stell Pm Survival times in end-stage head and neck cancer. , 1989 .

[24]  P. Stell Survival times in end-stage head and neck cancer. , 1989, European Journal of Surgical Oncology.

[25]  J. Skołyszewski,et al.  The reirradiation of recurrences of head and neck cancer. , 1980, The British journal of radiology.